Cervical cancer progression involves complex molecular interactions, with ACTL6A emerging as a critical oncoprotein in this malignancy.96-98 Functional studies revealed that ACTL6A promotes cervical cancer progression through oncogenic c-Myc interaction, where it stabilizes c-Myc protein levels and enhances its transcriptional activity. This evidence concerns the gene MYC and cervical cancer.